 |
市場調査レポート
商品コード
1373896
避妊用デバイスの世界市場 (2023-2030年)：製品・エンドユーザー別の規模・シェア・成長分析・予測Global Contraceptive Devices Market Size, Share, Growth Analysis, By Product(Condoms, Subdermal Implants), By End user(Male and Female) - Industry Forecast 2023-2030 |
||||||
| 避妊用デバイスの世界市場 (2023-2030年)：製品・エンドユーザー別の規模・シェア・成長分析・予測 |
|
出版日: 2023年10月13日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の避妊用デバイスの市場規模は、2021年の266億8,000万米ドル、2022年の283億米ドルから、予測期間中は6.06％のCAGRで推移し、2030年には453億1,000万米ドルの規模に成長すると予測されています。
避妊技術の画期的な進歩として、高効率の非ホルモン性子宮内避妊用デバイス (IUD) の開発が挙げられます。この革新的なデバイスは、女性に信頼性が高く、長持ちする避妊方法を提供します。このIUDは、安全性と使いやすさの両方を促進するユニークなデザインで、潜在的な副作用を最小限に抑え、手間のいらない避妊ソリューションとなっています。その有効性と使いやすさから、便利で信頼できる避妊法を求める女性にとって有望な選択肢となっています。
また、市場は、望まない妊娠率の上昇、家族計画技術に対する理解と利用の増加など、その他の多くの要因によっても牽引されています。さらに、STIの急増と家族計画プログラムに対する政府資金の増加も、市場成長を促進しています。また、コンドーム、子宮内避妊具、経口避妊薬、皮下インプラントなど、多くの避妊方法が利用可能であることや、消費者の消費意欲の高まりも、市場拡大に寄与しています。さらに、eコマース産業の台頭、長時間作用型の可逆的避妊薬の開発、製品イノベーションなども市場を押し上げています。これは、非ホルモン性避妊薬や天然避妊薬に対する需要の高まりや、女性主導の避妊技術の人気の高まりとも連動し、いずれも市場の拡大を後押ししています。
当レポートでは、世界の避妊用デバイスの市場を調査し、市場概要、市場への各種影響因子の分析、技術・イノベーションの動向、法規制環境、市場規模の推移・予測、各種区分・地域別の内訳、競合情勢、主要企業のプロファイルなどをまとめています。
目次
- エグゼクティブサマリー
- 調査手法
- 親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 主要な市場洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資分析
- 主要な成功要因
- 競合の程度
- 市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 市場力学
- 規制状況
- ポーターの分析
- 将来のディスラプションに関するSkyquestの特別な洞察
- 世界の避妊用デバイス市場：製品別
- 市場概要
- コンドーム
- 皮下インプラント
- 避妊薬
- 膣リング
- ダイヤフラム
- 世界の避妊用デバイス市場：エンドユーザー別
- 市場概要
- 男性
- 女性
- 世界の避妊用デバイス市場：地域別
- 市場概要
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ
- 競合情勢
- トップ5社の比較
- 主要企業の市場での位置付け
- 主要企業の採用戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア
- 主要企業プロファイル
- Bayer AG
- Pfizer Inc.
- Janssen Global Services, LLC
- Teva Pharmaceutical Industries Ltd.
- Merck Sharp & Dohme Corp.
- Mylan N.V.
- Reckitt Benckiser Group plc.
- Veru Inc.
- Medisafe Distribution Inc.
- CooperSurgical, Inc.
- Devex
- Mayer Laboratories, Inc.
- Allergan plc
- Agile Therapeutics
- HLL Lifecare
- ANSELL LTD
- Mankind Pharma
- TTK HealthCare
- Boehringer Ingelheim International GmbH
- V-Care Pharma Pvt. Ltd.
Global Contraceptive Devices Market size was valued at USD 26.68 billion in 2021 and is poised to grow from USD 28.3 billion in 2022 to USD 45.31 billion by 2030, growing at a CAGR of 6.06% during the forecast period (2023-2030).
To foster market growth, programs focused on reducing unintended pregnancies and associated healthcare costs and enhancing user awareness are anticipated. Numerous initiatives, such as Every Woman Every Child, Millennium Development Goals, the 2030 Sustainable Development Goals (SDGs), and Family Planning, have been launched by governments and healthcare organizations to promote family planning and the manufacturing and utilization of contraceptives. Private and public sectors both play significant roles as providers of contraceptives. The private sector primarily supplies short-acting resupply contraceptive methods like condoms and contraceptive pills, consistently holding a considerable market share. In Asia, for instance, around 41% of females obtain contraceptives from private-sector sources, while approximately 56% rely on public sources. Across 36 evaluated countries categorized as low- and middle-income, about 63% of women acquire contraceptives from the private sector, whereas approximately 34% utilize public-sector sources.
Top-down and bottom-up approaches were used to estimate and validate the size of the global Contraceptive Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Contraceptive Devices Market Segmental Analysis
Global Contraceptive Devices Market is segmented by product, end user, and region. Based on Product, the market can be segmented into condoms, subdermal implants, contraceptive drugs, vaginal rings, and diaphragms. Based on End user, the market is segmented into male and female. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Contraceptive Devices Market Dynamics
Drivers of the Global Contraceptive Devices Market
Development of a highly efficient
One groundbreaking advancement in contraceptive technology is the development of a highly efficient, non-hormonal intrauterine device (IUD). This innovative device offers women a reliable and long-lasting method of birth control. By utilizing a unique design that promotes both safety and ease of use, this IUD provides a hassle-free contraceptive solution while minimizing potential side effects. It's effectiveness and user-friendly nature make it a promising option for women seeking convenient and reliable contraception.
Restraints in the Global Contraceptive Devices
Market
Increasing risk of infections regarding the use of contraceptive devices
Contraceptive devices empower individuals to make informed choices about their reproductive health. By providing a reliable and accessible method of birth control, these devices promote reproductive autonomy and enable individuals to plan their families according to their personal circumstances. With a wide range of options available, including condoms, intrauterine devices (IUDs), and hormonal implants, contraceptive devices offer diverse choices to suit individual needs, fostering responsible sexual practices and reducing the risk of unintended pregnancies. Their availability promotes safer and healthier sexual experiences, ultimately empowering individuals to control their own reproductive journeys.
Market Trends of the Global Contraceptive Devices Key
The market is being driven by a number of factors, such as rising unwanted pregnancy rates and increased understanding and use of family planning techniques. Additionally, the soaring prevalence of STIs and the increased government financing for family planning programmes are promoting market expansion. The availability of numerous contraceptive methods, such as condoms, intrauterine devices, oral contraceptives, and subdermal implants, as well as rising consumer spending power, are also contributing to the market's expansion. In addition, the rise of the e-commerce industry, the development of long-acting reversible contraceptives, and the escalating trend of product innovations are boosting the market. This is in accordance with the growing demand for non-hormonal and natural contraceptives and the rising popularity of female-controlled contraceptive techniques, both of which are fostering market expansion.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Contraceptive Devices Market by Product
- Market Overview
- Condoms
- Subdermal Implants
- Contraceptive Drugs
- Vaginal Rings
- and Diaphragms
- Global Contraceptive Devices Market by End user
- Market Overview
- Male and Female
- Global Contraceptive Devices Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Janssen Global Services, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries Ltd. (Jerusalem)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck Sharp & Dohme Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mylan N.V. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Reckitt Benckiser Group plc. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Veru Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medisafe Distribution Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CooperSurgical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Devex (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mayer Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Allergan plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agile Therapeutics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- HLL Lifecare (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ANSELL LTD (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mankind Pharma (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- TTK HealthCare (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boehringer Ingelheim International GmbH. (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- V-Care Pharma Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
